269 related articles for article (PubMed ID: 32387702)
1. Nose-to-brain drug delivery system with ligand/cell-penetrating peptide-modified polymeric nano-micelles for intracerebral gliomas.
Kanazawa T; Taki H; Okada H
Eur J Pharm Biopharm; 2020 Jul; 152():85-94. PubMed ID: 32387702
[TBL] [Abstract][Full Text] [Related]
2. Cell-penetrating peptide-modified block copolymer micelles promote direct brain delivery via intranasal administration.
Kanazawa T; Taki H; Tanaka K; Takashima Y; Okada H
Pharm Res; 2011 Sep; 28(9):2130-9. PubMed ID: 21499835
[TBL] [Abstract][Full Text] [Related]
3. Prolongation of life in rats with malignant glioma by intranasal siRNA/drug codelivery to the brain with cell-penetrating peptide-modified micelles.
Kanazawa T; Morisaki K; Suzuki S; Takashima Y
Mol Pharm; 2014 May; 11(5):1471-8. PubMed ID: 24708261
[TBL] [Abstract][Full Text] [Related]
4. Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles.
Kanazawa T; Akiyama F; Kakizaki S; Takashima Y; Seta Y
Biomaterials; 2013 Dec; 34(36):9220-6. PubMed ID: 23992922
[TBL] [Abstract][Full Text] [Related]
5. Cell-Penetrating Peptide Modified PEG-PLA Micelles for Efficient PTX Delivery.
Shuai Q; Cai Y; Zhao G; Sun X
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182734
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.
Alex AT; Joseph A; Shavi G; Rao JV; Udupa N
Drug Deliv; 2016 Sep; 23(7):2144-2153. PubMed ID: 25544603
[TBL] [Abstract][Full Text] [Related]
7. TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors.
Sethuraman VA; Bae YH
J Control Release; 2007 Apr; 118(2):216-24. PubMed ID: 17239466
[TBL] [Abstract][Full Text] [Related]
8. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
[TBL] [Abstract][Full Text] [Related]
9. Intranasal delivery of camptothecin-loaded tat-modified nanomicells for treatment of intracranial brain tumors.
Taki H; Kanazawa T; Akiyama F; Takashima Y; Okada H
Pharmaceuticals (Basel); 2012 Oct; 5(10):1092-102. PubMed ID: 24281259
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging.
Asem H; Zhao Y; Ye F; Barrefelt Å; Abedi-Valugerdi M; El-Sayed R; El-Serafi I; Abu-Salah KM; Hamm J; Muhammed M; Hassan M
J Nanobiotechnology; 2016 Dec; 14(1):82. PubMed ID: 27993139
[TBL] [Abstract][Full Text] [Related]
11. Highly efficacious and specific anti-glioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides.
Zhu Y; Jiang Y; Meng F; Deng C; Cheng R; Zhang J; Feijen J; Zhong Z
J Control Release; 2018 May; 278():1-8. PubMed ID: 29596873
[TBL] [Abstract][Full Text] [Related]
12. All-stage precisional glioma targeted therapy enabled by a well-designed D-peptide.
Ran D; Zhou J; Chai Z; Li J; Xie C; Mao J; Lu L; Zhang Y; Wu S; Zhan C; Lu W
Theranostics; 2020; 10(9):4073-4087. PubMed ID: 32226540
[TBL] [Abstract][Full Text] [Related]
13. Conjugates of TAT and folate with DOX-loaded chitosan micelles offer effective intracellular delivery ability.
Zhang S; Liu Y; Gan Y; Qiu N; Gu Y; Zhu H
Pharm Dev Technol; 2019 Feb; 24(2):253-261. PubMed ID: 29688120
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles.
Kanazawa T; Kurano T; Ibaraki H; Takashima Y; Suzuki T; Seta Y
Pharmaceutics; 2019 Sep; 11(9):. PubMed ID: 31540164
[TBL] [Abstract][Full Text] [Related]
15. Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment.
Peng Y; Huang J; Xiao H; Wu T; Shuai X
Int J Nanomedicine; 2018; 13():3467-3480. PubMed ID: 29942129
[TBL] [Abstract][Full Text] [Related]
16. Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles.
Kanazawa T; Sugawara K; Tanaka K; Horiuchi S; Takashima Y; Okada H
Eur J Pharm Biopharm; 2012 Aug; 81(3):470-7. PubMed ID: 22579732
[TBL] [Abstract][Full Text] [Related]
17. A biodegradable pH-sensitive micelle system for targeting acidic solid tumors.
Sethuraman VA; Lee MC; Bae YH
Pharm Res; 2008 Mar; 25(3):657-66. PubMed ID: 17999164
[TBL] [Abstract][Full Text] [Related]
18. Construction of Dimeric Drug-Loaded Polymeric Micelles with High Loading Efficiency for Cancer Therapy.
Yu B; Meng Q; Hu H; Xu T; Shen Y; Cong H
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013608
[TBL] [Abstract][Full Text] [Related]
19. Transferrin modified PEG-PLA-resveratrol conjugates: in vitro and in vivo studies for glioma.
Guo W; Li A; Jia Z; Yuan Y; Dai H; Li H
Eur J Pharmacol; 2013 Oct; 718(1-3):41-7. PubMed ID: 24070814
[TBL] [Abstract][Full Text] [Related]
20. Novel pH-sensitive charge-reversal cell penetrating peptide conjugated PEG-PLA micelles for docetaxel delivery: in vitro study.
Ouahab A; Cheraga N; Onoja V; Shen Y; Tu J
Int J Pharm; 2014 May; 466(1-2):233-45. PubMed ID: 24614579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
